iBio Inc (IBIO)
1.76
+0.04
(+2.33%)
USD |
NYAM |
Apr 26, 16:00
1.76
0.00 (0.00%)
After-Hours: 20:00
iBio Free Cash Flow (Quarterly): -4.706M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -4.706M |
| September 30, 2023 | -5.34M |
| June 30, 2023 | -5.476M |
| March 31, 2023 | -3.671M |
| December 31, 2022 | -10.59M |
| September 30, 2022 | -16.44M |
| June 30, 2022 | -14.93M |
| March 31, 2022 | -8.021M |
| December 31, 2021 | -12.82M |
| September 30, 2021 | -13.34M |
| June 30, 2021 | -9.781M |
| March 31, 2021 | -8.366M |
| December 31, 2020 | -9.426M |
| September 30, 2020 | -7.653M |
| June 30, 2020 | -4.687M |
| March 31, 2020 | -3.882M |
| December 31, 2019 | -3.613M |
| September 30, 2019 | -2.317M |
| June 30, 2019 | -4.565M |
| March 31, 2019 | -4.274M |
| December 31, 2018 | -5.059M |
| September 30, 2018 | -1.067M |
| June 30, 2018 | -3.657M |
| March 31, 2018 | -3.985M |
| December 31, 2017 | -3.789M |
| Date | Value |
|---|---|
| September 30, 2017 | -3.128M |
| June 30, 2017 | -4.29M |
| March 31, 2017 | -3.864M |
| December 31, 2016 | -3.727M |
| September 30, 2016 | -2.875M |
| June 30, 2016 | -2.882M |
| March 31, 2016 | -2.439M |
| December 31, 2015 | -1.654M |
| September 30, 2015 | -1.165M |
| June 30, 2015 | -1.27M |
| March 31, 2015 | -1.377M |
| December 31, 2014 | -1.692M |
| September 30, 2014 | -0.601M |
| June 30, 2014 | -0.743M |
| March 31, 2014 | -1.345M |
| December 31, 2013 | -1.317M |
| September 30, 2013 | -0.97M |
| June 30, 2013 | -0.946M |
| March 31, 2013 | -1.293M |
| December 31, 2012 | -1.457M |
| September 30, 2012 | -1.348M |
| June 30, 2012 | -1.100M |
| March 31, 2012 | -3.020M |
| December 31, 2011 | -0.8139M |
| September 30, 2011 | -1.321M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-16.44M
Minimum
Sep 2022
-2.317M
Maximum
Sep 2019
-7.875M
Average
-7.653M
Median
Sep 2020
Free Cash Flow (Quarterly) Benchmarks
| Lixte Biotechnology Holdings Inc | -0.9021M |
| PAVmed Inc | -12.06M |
| Avalo Therapeutics Inc | -2.766M |
| Imunon Inc | -3.772M |
| Ocugen Inc | -14.02M |